Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Treasury Shares (2016 - 2025)

Sensus Healthcare has reported Treasury Shares over the past 9 years, most recently at $3.9 million for Q4 2025.

  • Quarterly results put Treasury Shares at $3.9 million for Q4 2025, up 8.54% from a year ago — trailing twelve months through Dec 2025 was $3.9 million (up 8.54% YoY), and the annual figure for FY2025 was $3.9 million, up 8.54%.
  • Treasury Shares for Q4 2025 was $593036.0 at Sensus Healthcare, roughly flat from $591809.0 in the prior quarter.
  • Over the last five years, Treasury Shares for SRTS hit a ceiling of $1.0 million in Q3 2022 and a floor of $28750.0 in Q2 2021.
  • Median Treasury Shares over the past 5 years was $129375.0 (2021), compared with a mean of $247331.2.
  • Biggest five-year swings in Treasury Shares: soared 956.31% in 2022 and later grew 1.32% in 2024.
  • Sensus Healthcare's Treasury Shares stood at $325000.0 in 2021, then soared by 956.31% to $3.4 million in 2022, then increased by 2.51% to $3.5 million in 2023, then increased by 1.48% to $3.6 million in 2024, then rose by 8.54% to $3.9 million in 2025.
  • The last three reported values for Treasury Shares were $3.9 million (Q4 2025), $3.9 million (Q3 2025), and $3.9 million (Q2 2025) per Business Quant data.